维普中文期刊产品整合服务
158篇 您的检索式:作者名="Velikova"
    题名 作者 年代 出处 被引量
1Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients显示文摘AIM To investigate T-cell activation, the percentage of peripheral T regulatory cells(Tregs), Th17 cells and the circulating cytokine profile in systemic sclerosis(SSc).METHODS We enrolled a total of 24 SSc patients and 16 healthy controls in the study and divided the patients as having diffuse cutaneous SSc(dc SSc, n = 13) or limited cutaneous SSc(lc SSc, n = 11). We performed a further subdivision of the patients regarding the stage of the disease-early, intermediate or late. Peripheral venous blood samples were collected from all subjects. We performed flow cytometric analysis of the activationcapacity of T-lymphocytes upon stimulation with PHA-M and of the percentage of peripheral Tregs and Th17 cells in both patients and healthy controls. We used ELISA to quantitate serum levels of human interleukin(IL)-6, IL-10, tissue growth factor-β1(TGF-β1), and IL-17 A.RESULTS We identified a decreased percentage of CD3+CD69+ cells in PHA-stimulated samples from SSc patients in comparison with healthy controls(13.35% ± 2.90% vs 37.03% ± 2.33%, P < 0.001). However, we did not establish a correlation between the down-regulated CD3+CD69+ cells and the clinical subset, nor regarding the stage of the disease. The activated CD4+CD25+ peripheral lymphocytes were represented in decreased percentage in patients when compared to controls(6.30% ± 0.68% vs 9.36% ± 1.08%, P = 0.016). Regarding the forms of the disease, dc SSc patients demonstrated lower frequency of CD4+CD25+ T cells against healthy subjects(5.95% ± 0.89% vs 9.36% ± 1.08%, P = 0.025). With regard to Th17 cells, our patients demonstrated increased percentage in comparison with controls(18.13% ± 1.55% vs 13.73% ± 1.21%, P = 0.031). We detected up-regulated Th17 cells within the lc SSc subset against controls(20.46% ± 2.41% vs 13.73% ± 1.21%, P = 0.025), nevertheless no difference was found between dc SSc and lc SSc patients. Flow cytometric analysis revealed an increased percentage of CD4+CD25-Foxp3+ in dc SSc patients compared to controls(10.94% ± 1.65% vs 6.88% ± 0.91, P = 0.032). Regarding the peripheral cytokine profile, we detected raised levels of IL-6 [2.10(1.05-4.60) pg/m L vs 0.00 pg/m L, P < 0.001], TGF-β1(19.94 ± 3.35 ng/m L vs 10.03 ± 2.25 ng/m L, P = 0.02), IL-10(2.83 ± 0.44 pg/m L vs 0.68 ± 0.51 pg/m L, P = 0.008), and IL-17 A [6.30(2.50-15.60) pg/m L vs 0(0.00-0.05) pg/m L, P < 0.001] in patients when compared to healthy controls. Furthermore, we found increased circulating IL-10, TGF-β, IL-6 and IL-17 A in the lc SSc subset vs control subjects, as it follows: IL-10(3.32 ± 0.59 pg/m L vs 0.68 ± 0.51 pg/m L, P = 0.003), TGF-β1(22.82 ± 4.99 ng/m L vs 10.03 ± 2.25 ng/m L, P = 0.031), IL-6 [2.08(1.51-4.69) pg/m L vs 0.00 pg/m L, P < 0.001], and IL-17 A [14.50(8.55-41.65) pg/m L vs 0.00(0.00-0.05) pg/m L, P < 0.001]. Furthermore, circulating IL-17 A was higher in lc SSc as opposed to dc SSc subset(31.99 ± 13.29 pg/m L vs 7.14 ± 3.01 pg/m L, P = 0.008). Within the dc SSc subset, raised levels of IL-17 A and IL-6 were detected vs healthy controls: IL-17 A [2.60(0.45-9.80) pg/m L vs 0.00(0.00-0.05) pg/m L, P < 0.001], IL-6 [2.80(1.03-7.23) pg/m L vs 0.00 pg/m L, P < 0.001]. Regarding the stages of the disease, TGF-β1 serum levels were increased in early stage against late stage, independently from the SSc phenotype(30.03 ± 4.59 ng/m L vs 13.08 ± 4.50 ng/m L, P = 0.017).CONCLUSION It is likely that the altered percentage of Th17 and CD4+CD25-Fox P3+ cells along with the peripheral cytokine profile in patients with SSc may play a key role in the pathogenesis of the disease.Ekaterina Krasimirova Tsvetelina Velikova Ekaterina Ivanova-Todorova Kalina Tumangelova-Yuzeir Desislava Kalinova Vladimira Boyadzhieva Nikolay Stoilov Tsvetelina Yoneva Rasho Rashkov Dobroslav Kyurkchiev 2017World Journal of Experimental Medicine2017,7,3:10
2Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer显示文摘BACKGROUND The connection between inflammatory bowel disease(IBD)and colorectal cancer(CRC)is well-established,as persistent intestinal inflammation plays a substantial role in both disorders.Cytokines may further influence the inflammation and the carcinogenesis process.AIM To compare cytokine patterns of active IBD patients with early and advanced CRC.METHODS Choosing a panel of cytokines crucial for Th17/Treg differentiation and behavior,in colon specimens,as mRNA biomarkers,and their serum protein levels.RESULTS We found a significant difference between higher gene expression of FoxP3,TGFb1,IL-10,and IL-23,and approximately equal level of IL-6 in CRC patients in comparison with IBD patients.After stratification of CRC patients,we found a significant difference in FoxP3,IL-10,IL-23,and IL-17A mRNA in early cases compared to IBD,and IL-23 alone in advanced CRC.The protein levels of the cytokines were significantly higher in CRC patients compared to IBD patients.CONCLUSION Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes(TGFb1,IL-10,IL-23,and transcription factor FoxP3)is a crucial primarily for CRC development.The significantly upregulated IL-6 could be a potential drug target for IBD and prevention of CRC development as well.Tsvetelina Veselinova Velikova Lyuba Miteva Noyko Stanilov Zoya Spassova Spaska Angelova Stanilova 2020World Journal of Gastroenterology2020,26,16:10
3Oxidative stress and some antioxidant systems in acid rain-treated bean plants显示文摘V Velikova I Yordanov A Edreva 2000Plant Science2000,,1:2
4The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views 显示文摘Velikova G Awad N Coles-Gale R 2008Psychooncology2008,17,7:1
5Oxidative stress and some antioxidant systems in acid rain-treated bean plants protective role of exogenous polyamines显示文摘VELIKOVA V YORDANOV I EDREVA A 2000Plant Sci2000,151,:1
6Chemical composition and biological activity of propolis from Turkish and Bulgarian Ori- gion 显示文摘Velikova M Bankova V Sorkun K 2001Mellifera2001,,1:1
7Factors affecting complications development and mortality after single lung transplant显示文摘Lung transplantation(LT)is a life-saving therapeutic procedure that prolongs survival in patients with end-stage lung disease.Furthermore,as a therapeutic option for high-risk candidates,single LT(SLT)can be feasible because the immediate morbidity and mortality after transplantation are lower compared to sequential single(double)LT(SSLTx).Still,the long-term overall survival is,in general,better for SSLTx.Despite the great success over the years,the early post-SLT period remains a perilous time for these patients.Patients who undergo SLT are predisposed to evolving early or late postoperative complications.This review emphasizes factors leading to post-SLT complications in the early and late periods including primary graft dysfunction and chronic lung allograft dysfunction,native lung complications,anastomosis complications,infections,cardiovascular,gastrointestinal,renal,and metabolite complications,and their association with morbidity and mortality in these patients.Furthermore,we discuss the incidence of malignancy after SLT and their correlation with immunosuppression therapy.Metodija Sekulovski Bilyana Simonska Milena Peruhova Boris Krastev Monika Peshevska-Sekulovska Lubomir Spassov Tsvetelina Velikova 2021World Journal of Transplantation2021,11,8:1
8Plant responses to drought, acclimation, and stress tolerance显示文摘Yordanov I Velikova V Tsonev T 2000Photosynthetic2000,38,:1
9Oxidative stress and some autioxidant systems in acid rain-treated bean plants:protective role of exogenous polyamines显示文摘Velikova V Yordanov I Edreva A 2000Plant Science2000,151,:1
10The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22显示文摘Chow E Hird A Velikova G 2009Eur J Cancer2009,45,7:1
11Learning Bayesian networks for clinical time series analysis 显示文摘van der Heijden M Velikova M Lucas PJ 2013J Biomed Inform2013,464,13:1
12On the interplay of machine learning and background knowledge in image in- terpretation by Bayesian networks显示文摘Velikova M Lucas P J F Samulski M 2013Artificial Intelligence in Medicine2013,57,1:1
13Plant Responses to Drought, Acclimation, and Stress Tolerance显示文摘I. Yordanov V. Velikova T. Tsonev 2000Photosynthetica2000,,2:1
14Oxidative stress and some antioxidant systems in acid rain-treated bean plants protective role of exogenous polyamines显示文摘Velikova V Yordanov I Edreva A 2000Plant Sci2000,151,:1
15Factor analysis kf anx- iety and depression among scale from a large cancer poprlation 显示文摘Smith AB Selby P J Velikova C 2002Psychol Psychother2002,75,:1
16Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial显示文摘Dan Stark Matthew Nankivell Eric Pujade-Lauraine Gunnar Kristensen Lorraine Elit Martin Stockler Felix Hilpert Andrés Cervantes Julia Brown Anne Lanceley Galina Velikova Eduardo Sabate Jacobus Pfisterer Mark S Carey Philip Beale Wendi Qian Ann Marie Swart 2013Lancet Oncology2013,,:1
17The European Organization forResearch and Treatment of Cancer Quality of Life Questionnairefor patients with bone metastases:The EORTC QLQ - BM22显示文摘Chow E Hird A Velikova G etal 2009Eur J Cancer2009,457,:1
18Oxidative stress and some antioxidant systems in acid rain-treated bean plants: Protective role of exogenous polyamines 显示文摘Velikova V Yordanov I Edreva A 2000Plant Science2000,151,1:1
19Oxidative stress and some antioxidant systems in acid rain-treated bean plants protective role of exogenous polyamines 显示文摘Velikova V Yordanov I Edreva A 2000Plant Sci2000,151,2:1
20Oxidative stress and some antioxidant systems in acid rain-treated beanplants:protective role of exogenous polyamines显示文摘Velikova V Yordanov I Edreva A 2000Plant Science2000,151,1:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费